191 related articles for article (PubMed ID: 7906414)
1. Combinatorially selected guanosine-quartet structure is a potent inhibitor of human immunodeficiency virus envelope-mediated cell fusion.
Wyatt JR; Vickers TA; Roberson JL; Buckheit RW; Klimkait T; DeBaets E; Davis PW; Rayner B; Imbach JL; Ecker DJ
Proc Natl Acad Sci U S A; 1994 Feb; 91(4):1356-60. PubMed ID: 7906414
[TBL] [Abstract][Full Text] [Related]
2. Potent and specific inhibition of HIV envelope-mediated cell fusion and virus binding by G quartet-forming oligonucleotide (ISIS 5320).
Buckheit RW; Roberson JL; Lackman-Smith C; Wyatt JR; Vickers TA; Ecker DJ
AIDS Res Hum Retroviruses; 1994 Nov; 10(11):1497-506. PubMed ID: 7888204
[TBL] [Abstract][Full Text] [Related]
3. Phosphorothioate oligodeoxycytidine interferes with binding of HIV-1 gp120 to CD4.
Stein CA; Neckers LM; Nair BC; Mumbauer S; Hoke G; Pal R
J Acquir Immune Defic Syndr (1988); 1991; 4(7):686-93. PubMed ID: 1711118
[TBL] [Abstract][Full Text] [Related]
4. Phosphorothioate and cordycepin analogues of 2',5'-oligoadenylate: inhibition of human immunodeficiency virus type 1 reverse transcriptase and infection in vitro.
Montefiori DC; Sobol RW; Li SW; Reichenbach NL; Suhadolnik RJ; Charubala R; Pfleiderer W; Modliszewski A; Robinson WE; Mitchell WM
Proc Natl Acad Sci U S A; 1989 Sep; 86(18):7191-4. PubMed ID: 2476814
[TBL] [Abstract][Full Text] [Related]
5. Azasugar-containing phosphorothioate oligonucleotide (AZPSON) DBM-2198 inhibits human immunodeficiency virus type 1 (HIV-1) replication by blocking HIV-1 gp120 without affecting the V3 region.
Lee J; Byeon SE; Jung JY; Kang MH; Park YJ; Jung KE; Bae YS
Mol Cells; 2015; 38(2):122-9. PubMed ID: 25623024
[TBL] [Abstract][Full Text] [Related]
6. Polydeoxyguanine motifs in a 12-mer phosphorothioate oligodeoxynucleotide augment binding to the v3 loop of HIV-1 gp120 and potency of HIV-1 inhibition independency of G-tetrad formation.
Lederman S; Sullivan G; Benimetskaya L; Lowy I; Land K; Khaled Z; Cleary AM; Yakubov L; Stein CA
Antisense Nucleic Acid Drug Dev; 1996; 6(4):281-9. PubMed ID: 9012864
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of phosphorothioate analogues of oligodeoxyribonucleotides and their antiviral activity against human immunodeficiency virus (HIV).
Matsukura M; Zon G; Shinozuka K; Stein CA; Mitsuya H; Cohen JS; Broder S
Gene; 1988 Dec; 72(1-2):343-7. PubMed ID: 3243433
[TBL] [Abstract][Full Text] [Related]
8. GEM 91--an antisense oligonucleotide phosphorothioate as a therapeutic agent for AIDS.
Agrawal S; Tang JY
Antisense Res Dev; 1992; 2(4):261-6. PubMed ID: 1363378
[No Abstract] [Full Text] [Related]
9. SPC3, a V3 loop-derived synthetic peptide inhibitor of HIV-1 infection, binds to cell surface glycosphingolipids.
Delézay O; Hammache D; Fantini J; Yahi N
Biochemistry; 1996 Dec; 35(49):15663-71. PubMed ID: 8961929
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of inhibition of HIV-1 infection in vitro by guanine-rich oligonucleotides modified at the 5' terminal by dimethoxytrityl residue.
Furukawa H; Momota K; Agatsuma T; Yamamoto I; Kimura S; Shimada K
Nucleic Acids Res; 1994 Dec; 22(25):5621-7. PubMed ID: 7530843
[TBL] [Abstract][Full Text] [Related]
11. Identification of a phosphodiester hexanucleotide that inhibits HIV-1 infection in vitro on covalent linkage of its 5'-end with a dimethoxytrityl residue.
Furukawa H; Momota K; Agatsuma T; Yamamoto I; Kimura S; Shimada K
Antisense Nucleic Acid Drug Dev; 1997 Jun; 7(3):167-75. PubMed ID: 9212907
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of human immunodeficiency virus type 1 infection in SCID-hu Thy/Liv mice by the G-quartet-forming oligonucleotide, ISIS 5320.
Stoddart CA; Rabin L; Hincenbergs M; Moreno M; Linquist-Stepps V; Leeds JM; Truong LA; Wyatt JR; Ecker DJ; McCune JM
Antimicrob Agents Chemother; 1998 Aug; 42(8):2113-5. PubMed ID: 9687417
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of a hydrophobic tripeptide on human immunodeficiency virus type 1 (HIV-1)-induced syncytium formation and viral infectivity.
Konopka K; Pretzer E; Düzgünes N
Biochem Biophys Res Commun; 1995 Mar; 208(1):75-81. PubMed ID: 7887968
[TBL] [Abstract][Full Text] [Related]
14. Kinetics of G-quartet-mediated tetramer formation.
Wyatt JR; Davis PW; Freier SM
Biochemistry; 1996 Jun; 35(24):8002-8. PubMed ID: 8672504
[TBL] [Abstract][Full Text] [Related]
15. Abasic oligodeoxyribonucleoside phosphorothioates: synthesis and evaluation as anti-HIV-1 agents.
Iyer RP; Uznanski B; Boal J; Storm C; Egan W; Matsukura M; Broder S; Zon G; Wilk A; Koziolkiewicz M
Nucleic Acids Res; 1990 May; 18(10):2855-9. PubMed ID: 2349087
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of human immunodeficiency virus activity by phosphorodithioate oligodeoxycytidine.
Marshall WS; Beaton G; Stein CA; Matsukura M; Caruthers MH
Proc Natl Acad Sci U S A; 1992 Jul; 89(14):6265-9. PubMed ID: 1378623
[TBL] [Abstract][Full Text] [Related]
17. Intramolecular G-quartet motifs confer nuclease resistance to a potent anti-HIV oligonucleotide.
Bishop JS; Guy-Caffey JK; Ojwang JO; Smith SR; Hogan ME; Cossum PA; Rando RF; Chaudhary N
J Biol Chem; 1996 Mar; 271(10):5698-703. PubMed ID: 8621435
[TBL] [Abstract][Full Text] [Related]
18. Effect of structural variations in cholesteryl-conjugated oligonucleotides on inhibitory activity toward HIV-1.
Farooqui F; Sarin PS; Sun D; Letsinger RL
Bioconjug Chem; 1991; 2(6):422-6. PubMed ID: 1805939
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of human immunodeficiency virus 1 replication in vitro by a self-stabilized oligonucleotide with 2'-O-methyl-guanosine-uridine quadruplex motifs.
Kuwasaki T; Hatta M; Takeuchi H; Takaku H
J Antimicrob Chemother; 2003 Apr; 51(4):813-9. PubMed ID: 12654739
[TBL] [Abstract][Full Text] [Related]
20. Phosphorothioate hammerhead ribozymes targeting a conserved sequence in the V3 loop region inhibit HIV-1 entry.
Zhang X; Iwatani Y; Shimayama T; Yamada R; Koito A; Xu Y; Sakai H; Uchiyama T; Hattori T
Antisense Nucleic Acid Drug Dev; 1998 Dec; 8(6):441-50. PubMed ID: 9918108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]